• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Needham analyst reiterates buy rating on Harmony Biosciences
14:35
Harmony Biosciences Announces Positive Results for Gastro-Resistant Pitolisant Formulation Study
13:14
Nov14
Mizuho Securities Analyst Reiterates Buy Rating on Harmony Biosciences Holdings
05:48
Nov4
Harmony Biosciences released FY2025 9 Months Earnings on November 4 Pre-Market EST, actual revenue USD 624.68 M, actual EPS USD 2.3299
14:30
Harmony Biosciences released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 239.46 M (forecast USD 222.68 M), actual EPS USD 0.87 (forecast USD 0.6619)
14:30
Oct28
Harmony Biosciences to Release FY2025 Q3 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 222.68M, EPS USD 0.6742
00:35

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 239.46 M, Net Income 50.87 M, EPS 0.87

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 200.49 M, Net Income 39.78 M, EPS 0.6799

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 184.73 M, Net Income 45.56 M, EPS 0.7799

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
18.676
+176.36%
+11.919
SMX
297.005
+110.64%
+156.005
GURE
8.980
+89.45%
+4.240
WHLR
5.718
+76.47%
+2.570
DBRG
13.920
+43.21%
+4.209
TDIC
0.3776
+34.47%
+0.097
LICN
3.860
+31.74%
+0.980
TORO
5.425
+31.36%
+1.295
ALMS
10.870
+30.96%
+2.570
PRAX
247.830
+30.46%
+57.860
View More